Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
482,287,996
-
Share change
-
-12,751,809
-
Total reported value
-
$45,402,624,302
-
Put/Call ratio
-
78%
-
Price per share
-
$94.33
-
Number of holders
-
1,243
-
Value change
-
-$1,069,739,915
-
Number of buys
-
519
-
Number of sells
-
541
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2023
As of 30 Jun 2023,
Edwards Lifesciences Corp - Common Stock (EW) was held by
1,243 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
482,287,996 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital International Investors, ALLIANCEBERNSTEIN L.P., Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, BROWN ADVISORY INC, GEODE CAPITAL MANAGEMENT, LLC, and NORGES BANK.
This page lists
1,271
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.